Camsing Healthcare Limited (SGX:BAC)

Camsing Healthcare Income Statement

Financials in millions SGD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Revenue	4.19	4.78	4.85	6.1	5.53	5.69
Revenue Growth (YoY)	-2.76%	-1.42%	-20.50%	10.36%	-2.81%	-22.14%
Cost of Revenue	1.89	2.04	1.87	2.59	2.67	2.31
Gross Profit	2.3	2.74	2.98	3.51	2.86	3.38
Selling, General & Admin	4.09	5.33	4.96	5.53	4.68	4.93
Operating Expenses	4.1	5.35	4.97	5.53	4.68	4.93
Operating Income	-1.8	-2.61	-1.99	-2.02	-1.82	-1.56
Interest Expense	-0.09	-0.29	-0.57	-0.48	-0.17	-0.18
Interest & Investment Income	0.16	0.16	-	-	-	0.01
Other Non Operating Income (Expenses)	-0.57	0.35	0.05	0.06	0.13	0.1
EBT Excluding Unusual Items	-2.3	-2.4	-2.51	-2.44	-1.86	-1.62
Gain (Loss) on Sale of Investments	-	-	-	-	-	0.02
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.02
Asset Writedown	-1.24	-1.24	-0.21	0.04	-0.19	-0.37
Other Unusual Items	1.34	1.34	-	-	0.69	1.13
Pretax Income	-2.21	-2.3	-2.72	-2.4	-1.35	-0.83
Income Tax Expense	-	-	-	-	-0.02	-
Earnings From Continuing Operations	-2.21	-2.3	-2.72	-2.4	-1.33	-0.83
Minority Interest in Earnings	-	-	0	-0	0	0
Net Income	-2.21	-2.3	-2.72	-2.41	-1.33	-0.83
Net Income to Common	-2.21	-2.3	-2.72	-2.41	-1.33	-0.83
Shares Outstanding (Basic)	91	65	30	30	30	30
Shares Outstanding (Diluted)	91	65	30	30	30	30
Shares Change (YoY)	83.66%	115.62%	-	0.07%	-0.07%	-
EPS (Basic)	-0.02	-0.04	-0.09	-0.08	-0.04	-0.03
EPS (Diluted)	-0.02	-0.04	-0.09	-0.08	-0.04	-0.03
Free Cash Flow	-0.55	-1.59	0.33	-0.73	0.64	2.06
Free Cash Flow Per Share	-0.01	-0.03	0.01	-0.02	0.02	0.07
Gross Margin	54.93%	57.27%	61.46%	57.51%	51.70%	59.35%
Operating Margin	-43.01%	-54.51%	-40.99%	-33.03%	-32.93%	-27.33%
Profit Margin	-52.73%	-48.13%	-56.10%	-39.41%	-24.01%	-14.55%
Free Cash Flow Margin	-13.09%	-33.16%	6.70%	-11.96%	11.54%	36.19%
EBITDA	-1.77	-2.56	-1.91	-1.92	-1.72	-1.35
EBITDA Margin	-42.18%	-53.61%	-39.32%	-31.51%	-31.09%	-23.71%
D&A For EBITDA	0.04	0.04	0.08	0.09	0.1	0.21
EBIT	-1.8	-2.61	-1.99	-2.02	-1.82	-1.56
EBIT Margin	-43.01%	-54.51%	-40.99%	-33.03%	-32.93%	-27.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.